3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer
R E Coleman, R D Rubens, R E Coleman, R D Rubens
Abstract
The effect of a single dose of APD on hypercalcaemia has been studied in advanced breast cancer. Twenty-five patients were rehydrated intravenously for 48 h. Twenty-three remained hypercalcaemic and received 5-15 mg APD as a 2 h infusion. Eighteen patients achieved normocalcaemia, 15 after a dose of less than or equal to 15 mg. One patient died within 24 h from rapidly advancing disease and 4 remained hypercalcaemic. Urinary calcium excretion increased during rehydration as glomerular function improved and tubular reabsorption of calcium fell. After APD, calcium excretion fell to normal in 22/24 patients reflecting inhibition of bone resorption. Hydroxyproline excretion remained high. The effect of a single dose of APD on hypercalcaemia lasted a median of 11 days (range 7-17). Transient fever occurred in 2 patients, but there were no other side effects. The possibility of long-term control of osteolysis using a 2 weekly schedule of APD administration is now being studied.
References
- Lancet. 1969 Feb 22;1(7591):384-6
- Br Med J (Clin Res Ed). 1987 Feb 21;294(6570):467-9
- Clin Chim Acta. 1974 Dec 17;57(3):217-23
- Nature. 1976 Oct 7;263(5577):507-8
- Calcif Tissue Int. 1980;32(2):145-57
- Cancer. 1981 Jun 15;47(12):2803-6
- Q J Med. 1980 Autumn;49(196):405-18
- Am J Med. 1982 Feb;72(2):221-6
- Lancet. 1983 Jan 22;1(8317):146-9
- Cancer. 1983 Aug 15;52(4):610-4
- Lancet. 1983 Jul 30;2(8344):239-43
- Br J Surg. 1984 Feb;71(2):105-8
- Br Med J (Clin Res Ed). 1984 May 12;288(6428):1405-8
- Br Med J (Clin Res Ed). 1984 Aug 4;289(6440):287
- Eur J Cancer Clin Oncol. 1984 Jul;20(7):865-9
- Br J Cancer. 1985 May;51(5):665-9
- J Clin Invest. 1985 Aug;76(2):391-4
- Br Med J (Clin Res Ed). 1985 Sep 21;291(6498):776-9
- Lancet. 1985 Oct 26;2(8461):907-10
- Lancet. 1986 Mar 15;1(8481):615-6
- Clin Endocrinol (Oxf). 1985 Dec;23(6):705-14
- Br Med J (Clin Res Ed). 1986 Jun 14;292(6535):1549-50
- Eur J Cancer Clin Oncol. 1986 Apr;22(4):493-500
- Br J Cancer. 1987 Jan;55(1):61-6
- Clin Chim Acta. 1971 Dec;35(2):483-9
Source: PubMed